123 related articles for article (PubMed ID: 9182904)
1. Immunomodulatory effects of linomide in animals immunized with immunopathogenic retinal antigens: dissociation between different immune functions.
Shirkey BL; Slavin S; Vistica BP; Podgor MJ; Gery I
Clin Exp Immunol; 1997 Jun; 108(3):539-44. PubMed ID: 9182904
[TBL] [Abstract][Full Text] [Related]
2. Orally induced bystander suppression in experimental autoimmune uveoretinitis occurs only in the periphery and not in the eye.
Wildner G; Thurau SR
Eur J Immunol; 1995 May; 25(5):1292-7. PubMed ID: 7774632
[TBL] [Abstract][Full Text] [Related]
3. Prevention of experimental autoimmune uveoretinitis by intrathymic S-antigen injection.
Koevary SB; Caspi RR
Ocul Immunol Inflamm; 1997 Sep; 5(3):165-72. PubMed ID: 9326761
[TBL] [Abstract][Full Text] [Related]
4. Effects of a new immunosuppressive agent, FK506, on experimental autoimmune uveoretinitis in rats.
Kawashima H; Fujino Y; Mochizuki M
Invest Ophthalmol Vis Sci; 1988 Aug; 29(8):1265-71. PubMed ID: 2458329
[TBL] [Abstract][Full Text] [Related]
5. Suramin treatment suppresses induction of experimental autoimmune uveoretinitis (EAU) in rodents.
Sartani G; Silver PB; Strassmann G; Chan CC; Caspi RR
Curr Eye Res; 1995 Oct; 14(10):887-96. PubMed ID: 8549154
[TBL] [Abstract][Full Text] [Related]
6. Immunomodulation of experimental autoimmune myasthenia gravis with linomide.
Karussis DM; Lehmann D; Brenner T; Wirguin I; Mizrachi-Koll R; Sicsic C; Abramsky O
J Neuroimmunol; 1994 Dec; 55(2):187-93. PubMed ID: 7829669
[TBL] [Abstract][Full Text] [Related]
7. Protective effect of the type IV phosphodiesterase inhibitor rolipram in EAU: protection is independent of IL-10-inducing activity.
Xu H; Strassmann G; Chan CC; Rizzo LV; Silver PB; Wiggert B; Caspi RR
Invest Ophthalmol Vis Sci; 1999 Apr; 40(5):942-50. PubMed ID: 10102291
[TBL] [Abstract][Full Text] [Related]
8. Human immunoglobulin preparations for intravenous use prevent experimental autoimmune uveoretinitis.
Saoudi A; Hurez V; de Kozak Y; Kuhn J; Kaveri SV; Kazatchkine MD; Druet P; Bellon B
Int Immunol; 1993 Dec; 5(12):1559-67. PubMed ID: 8312226
[TBL] [Abstract][Full Text] [Related]
9. Interphotoreceptor retinoid binding protein is a potent tolerogen in Lewis rat: suppression of experimental autoimmune uveoretinitis is retinal antigen specific.
Laliotou B; Liversidge J; Forrester JV; Dick AD
Br J Ophthalmol; 1997 Jan; 81(1):61-7. PubMed ID: 9135411
[TBL] [Abstract][Full Text] [Related]
10. Protective effect of intravitreal administration of tresperimus, an immunosuppressive drug, on experimental autoimmune uveoretinitis.
Bousquet E; Camelo S; Leroux les Jardins G; Goldenberg B; Naud MC; Besson-Lescure B; Lebreton L; Annat J; Behar-Cohen F; de Kozak Y
Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5414-23. PubMed ID: 21666239
[TBL] [Abstract][Full Text] [Related]
11. TH2 activated cells prevent experimental autoimmune uveoretinitis, a TH1-dependent autoimmune disease.
Saoudi A; Kuhn J; Huygen K; de Kozak Y; Velu T; Goldman M; Druet P; Bellon B
Eur J Immunol; 1993 Dec; 23(12):3096-103. PubMed ID: 8258322
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of acute, experimental autoimmune encephalomyelitis by the synthetic immunomodulator linomide.
Karussis DM; Lehmann D; Slavin S; Vourka-Karussis U; Mizrachi-Koll R; Ovadia H; Ben-Nun A; Kalland T; Abramsky O
Ann Neurol; 1993 Nov; 34(5):654-60. PubMed ID: 8239559
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of experimental autoimmune uveoretinitis with anti-macrophage migration inhibitory factor antibodies.
Kitaichi N; Matsuda A; Kotake S; Namba K; Tagawa Y; Sasamoto Y; Ogasawara K; Iwabuchi K; Onoé K; Matsuda H; Nishihira J
Curr Eye Res; 2000 Feb; 20(2):109-14. PubMed ID: 10617911
[TBL] [Abstract][Full Text] [Related]
14. Protective effect of intravitreal injection of vasoactive intestinal peptide-loaded liposomes on experimental autoimmune uveoretinitis.
Camelo S; Lajavardi L; Bochot A; Goldenberg B; Naud MC; Brunel N; Lescure B; Klein C; Fattal E; Behar-Cohen F; de Kozak Y
J Ocul Pharmacol Ther; 2009 Feb; 25(1):9-21. PubMed ID: 19232006
[TBL] [Abstract][Full Text] [Related]
15. Antigen-specific suppressor cells induced by FK506 in experimental autoimmune uveoretinitis in the rat.
Kawashima H; Fujino Y; Mochizuki M
Invest Ophthalmol Vis Sci; 1990 Dec; 31(12):2500-7. PubMed ID: 1702408
[TBL] [Abstract][Full Text] [Related]
16. A new model of autoimmune disease. Experimental autoimmune uveoretinitis induced in mice with two different retinal antigens.
Caspi RR; Roberge FG; Chan CC; Wiggert B; Chader GJ; Rozenszajn LA; Lando Z; Nussenblatt RB
J Immunol; 1988 Mar; 140(5):1490-5. PubMed ID: 3346541
[TBL] [Abstract][Full Text] [Related]
17. Linomide-induced suppression of experimental autoimmune neuritis is associated with down-regulated macrophage functions.
Bai XF; Shi FD; Zhu J; Xiao BG; Hedlund G; Link H
J Neuroimmunol; 1997 Jun; 76(1-2):177-84. PubMed ID: 9184648
[TBL] [Abstract][Full Text] [Related]
18. Tacrolimus-rapamycin combination therapy for experimental autoimmune uveoretinitis.
Ikeda E; Hikita N; Eto K; Mochizuki M
Jpn J Ophthalmol; 1997; 41(6):396-402. PubMed ID: 9509307
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of experimental autoimmune uveoretinitis by mercuric chloride injections in (Lewis x Brown Norway) F1 hybrid rats.
Saoudi A; Bellon B; de Kozak Y; Vial MC; Thillaye B; Druet P
Curr Eye Res; 1990; 9 Suppl():135-8. PubMed ID: 2384007
[TBL] [Abstract][Full Text] [Related]
20. Prevention of experimental autoimmune uveoretinitis by vasoactive intestinal peptide.
Keino H; Kezuka T; Takeuchi M; Yamakawa N; Hattori T; Usui M
Arch Ophthalmol; 2004 Aug; 122(8):1179-84. PubMed ID: 15302659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
